Based on our founding team’s experiences within pharma and from the outside at consulting firms, it was clear that the old marketing playbook no longer worked as evolving technology outpaced pharma’s ability to adapt.
Our founding team knew there was a way forward to achieve a more effective, personal, and impactful model. They took a chance, building a platform and launching with their first commercial client in an oncology indication within large pharma.
Early results were clear–this solution drove ROI. The team expanded within commercial portfolios and to new clients, and then a new opportunity appeared.
Pharma has long battled challenges in clinical recruitment, and new models to promote trials to HCPs and patients became increasingly vital in a digital-first world. This led to the first application of the PFIQ platform outside commercial pharma, and use cases within Clinical and Medical teams rapidly proliferated.
In another nod to the team’s unique ability to defy conventional norms, PharmaForceIQ launched with enterprise pharma clients then grew into midsized and small pharma.
No matter the scale of the company, commercial and pre-commercial teams all have something in common: needing to find smarter, faster ways forward that go beyond outdated approaches and deliver meaningful impact.
As we grew, we expanded into more therapeutic areas, including rare diseases, endocrinology, dermatology, and beyond. And white-glove service has continued to be a central focus for every campaign, as our work isn’t meaningful unless it creates real value for our clients.
We are proud to have achieved 100% renewals across our clients. That’s a testament to the hard work our team puts in every day so clients know we’re a true strategic partner.
PharmaForceIQ has continued to work with additional brands and clients every year. So we could continue to serve existing clients and expand our work, we received a growth investment from Eir Partners in 2024.
This capital is being invested in product development and new features. We’re also growing our team and continuing to expand data assets that are enhancing our offerings to engage both HCP and DTC audiences.
As technology and AI open new doors, we’re partnering with clients to cement optichannel strategy as the next evolution of customer engagement. We recently acquired the industry’s premier field orchestration platform, Aktana, to further this mission.
This transparent, data-driven path to success moves beyond the limitations of the old media playbook and the disappointment that clouds omnichannel. So join us in using technology and data to win in new ways, engage customers more effectively, and justify every dollar spent.
Strategy
With over 15 years of pharma marketing experience from roles at Merck, AstraZeneca, IQVIA, and other firms, Hemal leads multiple business functions and advises clients on strategy.
Operations
Stephen oversees operational functions and client relationships. He is a commercialization strategy expert, with more than 15 years of experience at BeiGene, PwC, Deloitte, and IQVIA.
Product
Derek is a product‑driven technology leader and entrepreneur with deep experience in building and scaling AI‑powered solutions, fostering innovation, and delivering customer‑centric products.
Data Science
With AI and IT expertise in digital marketing and sales platforms, autonomous robotics, and more, Mateo has bridged advanced AI research with real-world engineering for eBay, Netflix, Volvo, and other global brands.
Marketing
Sarah leads marketing activities for PFIQ, applying her industry expertise from life science-focused roles at Phreesia, MedThink (a Fingerpaint Group company), and other organizations.
Finance
Mark has extensive experience leading finance teams at Saas technology companies including dominKnow, Inform, and Itential most recently.
Customer Engagement
Saraiyah is driven by a deep passion for marketing, strategy, From biopharma strategy consulting to leading omnichannel marketing campaigns, she thrives at the intersection of innovation and meaningful change.
Business Solutions
Kevin has two decades of experience helping biopharma leaders solve pressing commercial challenges to drive impact for patients and brands alike, including at Amplity Health, Delta Point, and Endo Pharmaceuticals.
Data Analysis
Aditya leads PharmaForceIQ’s data analysis team, transforming complex healthcare datasets into strategic insights that drive commercial, medical, and market access decisions.
As we build the future of pharma customer engagement, we frequently share insights at conferences, on podcasts, in publications and beyond so you can move from theory to real execution.
See why we’re throwing out the traditional media playbook
Hear from founder Stephen Onikoro on marketing evolution
Hear from PFIQ’s Kevin O’Connell at Pharma USA
At PharmaForceIQ, we are always on the lookout for passionate individuals who want to drive transformation and ultimately help improve healthcare outcomes. Explore our career opportunities and take the next step in your professional journey.
